Wednesday, November 13, 2013 9:10:40 AM
Evogene is one of the best performers among bio comps on TASE and is call 'the better half of Compugen' 
I like them but don't have the skills to really understand their platform, but MON seems to believe in their abilities and has a 8.6% stake in EVGN and this could increase to 9.4% after EVGN's US IPO, upper limit price for MON is $17/share.
I like them but don't have the skills to really understand their platform, but MON seems to believe in their abilities and has a 8.6% stake in EVGN and this could increase to 9.4% after EVGN's US IPO, upper limit price for MON is $17/share.
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
